LayerBio
Home Cataracts OcuRing™ Technology News & Events
HomeCataractsOcuRing™ TechnologyNews & Events
LayerBio

LayerBio CEO Presents OcuRing-K™ at OIS Anterior Innovation Showcase

Dr. Ken Mandell, Founder and CEO of LayerBio, presented an update on the development of its novel OcuRing-K™ ketorolac implant for treatment of postoperative pain and inflammation with cataract surgery.

OIS Anterior Innovation Showcase 2021

Kenneth MandellApril 9, 2021
Facebook0 Twitter 0 Likes
Previous

LayerBio wins Best Pitch at Octane's Ophthalmology Tech Summit

Kenneth MandellJuly 9, 2021
Next

LayerBio's CEO Gives Keynote at Drug Delivery Summit

Kenneth MandellMarch 16, 2021
LayerBio
info@layerbio.com
Hours